GLAXF - GlaxoSmithKline PLC (GSK) CEO Emma Walmsley on Q3 2020 Results - Earnings Call Transcript

GlaxoSmithKline PLC (GSK) Q3 2020 Earnings Conference Call October 28, 2020 10:00 AM ET Company Participants Sarah Elton-Farr - Head of Investor Relations Emma Walmsley - Chief Executive Officer Iain Mackay - Chief Financial Officer Luke Miels - President, Global Pharmaceuticals David Redfern - Chief Strategy Officer Brian McNamara - Chief Executive Officer, Consumer Healthcare Hal Barron - Chief Scientific Officer, President of R&D and Director Conference Call Participants Keyur Parekh - Goldman Sachs Group Graham Parry - Bank of America Tim Anderson - Wolfe Research James Gordon - JPMorgan Steve Scala - Cowen Andrew Baum - Citi Kerry Holford - Berenberg Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the analyst call on the GSK Third Quarter 2020 Results. I will now hand over to Sarah Elton-Farr, Head of Investor Relations, who will introduce today's session. Please go ahead Sarah. Sarah Elton-Farr Thank you. Good morning and

For further details see:

GlaxoSmithKline PLC (GSK) CEO Emma Walmsley on Q3 2020 Results - Earnings Call Transcript